import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡ AI æ±ºç­–ç³»çµ± (è¦–è¦ºè£œå®Œ & AI ä¿®å¾©ç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === æ¥µè‡´ç·Šç·»åŒ– UI === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé›¶ç•™ç™½è¨­è¨ˆ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent;
        background: white; margin-bottom: 4px; overflow: hidden;
        height: auto !important; min-height: 0 !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center; margin: 0 !important;
    }

    /* å­å€å¡Š (SoC)ï¼šæ¥µå°é‚Šè· */
    .sub-block {
        margin: 2px 4px; padding: 4px;
        border-radius: 6px; background: #F8F9FA;
        border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
        margin-bottom: 2px;
    }

    /* éšæ®µé¡è‰²å®šç¾© */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* ç‰¹æ®Šæ¨™ç±¤ */
    .tag-nsmp { color: #6A1B9A; font-weight: 900; }
    .tag-highlight { color: #D84315; font-weight: 800; }

    /* --- è©¦é©—æŒ‰éˆ•æ¨™è¨˜ï¼šæ·±è‰²å­—é«”ã€é«˜è¾¨è­˜åº¦é…è‰² --- */
    .stPopover button { 
        font-weight: 900 !important; font-size: 12px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 0px 5px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; /* æ·±é»‘è‰²å­—é«” */
        border: 1.5px solid rgba(0,0,0,0.1) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    /* è—¥å» èƒŒæ™¯é…è‰² (é«˜æ˜åº¦æ·ºè‰²ç³») */
    .stPopover button[aria-label*="Eli Lilly"] { background: #FCE4EC !important; border-left: 5px solid #E91E63 !important; } 
    .stPopover button[aria-label*="Daiichi Sankyo"] { background: #E8F5E9 !important; border-left: 5px solid #4CAF50 !important; } 
    .stPopover button[aria-label*="MSD"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; } 
    .stPopover button[aria-label*="AstraZeneca"] { background: #F3E5F5 !important; border-left: 5px solid #8E24AA !important; } 
    .stPopover button[aria-label*="GSK"] { background: #FFF3E0 !important; border-left: 5px solid #F57C00 !important; } 
    .stPopover button[aria-label*="Gilead"] { background: #E1F5FE !important; border-left: 5px solid #03A9F4 !important; } 
    .stPopover button[aria-label*="Seagen"] { background: #EEEEEE !important; border-left: 5px solid #212121 !important; } 

    /* æ·±åº¦çœ‹æ¿ */
    .detail-section { background: white; border-radius: 18px; padding: 25px; margin-top: 10px; border: 1px solid #CFD8DC; }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 50px !important; font-weight: 900; color: #D84315; }
    .pharma-badge { background: #37474F; color: white; padding: 4px 15px; border-radius: 50px; font-size: 13px; font-weight: 700; display: inline-block; margin-bottom: 8px; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å¤§ç¶±æ•¸æ“šåº« (NSMP æ·±åº¦è£œå®Œ) ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "POLEmut (è¶…çªè®Šå‹)", "content": "é å¾Œæœ€ä½³ã€‚FIGO 2023 å»ºè­°æ—©æœŸå¯è€ƒæ…®é™éš (De-escalation)ï¼Œå¯é¿å…éåº¦æ”¾åŒ–ç™‚ã€‚"},
            {"title": "MMRd / MSI-H", "content": "å…ç–«é«˜åº¦æ•æ„Ÿã€‚ä¸€ç·šæ¨™ç«¿ï¼šChemo + PD-1 (GY018/RUBY) â†’ IO ç¶­æŒæ²»ç™‚ã€‚"},
            {"title": "p53abn (Copy-number high)", "content": "ä¾µè¥²æ€§æ¥µé«˜ã€‚æ—©æœŸäº¦å»ºè­°å‡ç´šæ²»ç™‚ (åŒ–æ”¾ç™‚åˆä½µ)ï¼›Serous äºå‹å‹™å¿…è©•ä¼° HER2ã€‚"},
            {"title": "NSMP (No Specific Molecular Profile)", "content": "<span class='tag-nsmp'>åˆ¤å®šï¼šIHC MMR Intact / p53 wt / POLE wtã€‚</span><br>1. <span class='tag-highlight'>ç•°è³ªæ€§åˆ†å±¤:</span> é å¾Œå–æ±ºæ–¼ ER ç‹€æ…‹ã€Grade èˆ‡æ˜¯å¦é¡¯è‘— LVSIã€‚<br>2. <span class='tag-highlight'>è‡¨åºŠæ±ºç­–:</span> NSMP ER-negative å±¬é«˜é¢¨éšªå­ç¾¤ï¼›ER-positive ä¸”ç—…ç¨‹ç·©æ…¢è€…ï¼Œå¯è©•ä¼°è·çˆ¾è’™æ²»ç™‚ (AI/Progestin) ä½œç‚ºåºåˆ—ç®¡ç†ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "é‡å°æ™šæœŸ/å¾©ç™¼ä¸€ç·š Chemo-IO å¾Œï¼Œå»¶çºŒå…ç–«è—¥ç‰©ç¶­æŒç›´è‡³ç–¾ç—…é€²å±• (PD)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "MMRd / MSI-H", "content": "PD-1 æŠ‘åˆ¶åŠ‘å–®è—¥é«˜åæ‡‰ã€‚"}, {"title": "pMMR / NSMP", "content": "æ¨™æº–æ–¹æ¡ˆï¼šPembrolizumab + Lenvatinib (SoC)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Tx", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ°ä¸å¯è€å—æˆ– PDã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "æ‰‹è¡“ (PDS/IDS) + Carboplatin/Paclitaxel x6 Â± Bevacizumab"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "1. <span class='tag-highlight'>é‘‘åˆ¥:</span> CK7+/SATB2- åŸç™¼ã€‚2. <span class='tag-highlight'>å‹æ…‹:</span> Expansile (é å¾Œä½³) vs Infiltrative (é«˜å¾©ç™¼é¢¨éšª)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥æˆ– Olaparib+Bev (è‹¥ä¸€ç·šå·²å«Bev)"},
            {"title": "HRD positive (wt)", "content": "ä¸€ç·šå«Bevé¸ Olaparib+Bevï¼›æœªç”¨Bevé¸ Niraparib"},
            {"title": "HRD negative / pHRD", "content": "ç”¨éBevå‰‡çºŒç”¨ï¼›æœªç”¨å‰‡è§€å¯Ÿï¼Œè¦–é¢¨éšªæƒ…æ³é¸ç”¨ Niraparib"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive)", "content": "å«é‰‘é›™è—¥åŒ–ç™‚ Â± Bevacizumabï¼›æ¨™é¶ä¾ Biomarker æª¢æ¸¬é¸ç”¨ã€‚"},
            {"title": "PROC (Resistant)", "content": "å–®è—¥åŒ–ç™‚ Â± Bev æˆ– Elahere (FRÎ±+) æˆ– ADC è‡¨åºŠè©¦é©—ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive", "content": "é‰‘é¡æ•‘æ´ç·©è§£å¾ŒçºŒä»¥ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [{"title": "Surgery / CCRT / 1L", "content": "Surgery(æ—©æœŸ), CCRT(LA), Pembro+ChemoÂ±Bev(è½‰ç§»)"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic IO Maint", "content": "è½‰ç§»æ€§ä¸€ç·šå¾Œå»¶çºŒ Pembro ç¶­æŒç›´åˆ° PD"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "2L / 3L Therapy", "content": "Tisotumab vedotin (Tivdak) æˆ– Cemiplimab"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Tx", "content": "åŒä¸€ç·šæœ‰æ•ˆæ–¹æ¡ˆæŒçºŒçµ¦è—¥ç›´è‡³é€²å±•"}]}
    ]
}

# --- 2. æ·±åº¦è‡¨åºŠè©¦é©—è³‡æ–™åº« (8 æ ¸å¿ƒ æ¥µé‡åŒ–è£œå®Œ) ---
if 'trials_db' not in st.session_state:
    st.session_state.trials_db = [
        {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PSOC", "PROC"], 
         "rationale": "æ¨™é¶ FRÎ± ADCï¼Œæ­è¼‰é¡å¾®ç®¡è›‹ç™½è¼‰è·ã€‚è¯ç”¨ Bevacizumab å¯ç”¢ç”Ÿè¡€ç®¡é‡å¡‘å”åŒæ•ˆæ‡‰ (Synergy)ï¼Œæå‡ ADC æ»²é€åŠ›ã€‚æ—¨åœ¨è§£æ±º PARPi è€è—¥å¾Œæ‚£è€…ä¹‹ Unmet Needsã€‚",
         "dosing": {
             "Exp Arm (Part A/B)": "LY4170156 3 mg/kg IV + Bevacizumab 15 mg/kg IV Q3Wã€‚",
             "Control (Part A)": "TPC (Pacli, PLD, Gem, Top) æˆ– MIRV (Elahere)ã€‚",
             "Control (Part B)": "æ¨™æº–å«é‰‘é›™è—¥ (Platinum doublet) + Bevacizumab 15 mg/kg Q3Wã€‚"
         },
         "outcomes": {"ORR": "Ph 1/2: ~35-40%", "mPFS": "ä¸»è¦çµ‚é»", "HR": "Phase 3 é€²è¡Œä¸­", "CI": "NCT06536348", "AE": "Proteinuria, Hypertension"},
         "inclusion": [
             "18æ­²ä»¥ä¸Šï¼Œçµ„ç¹”å­¸è­‰å¯¦ç‚º HG Serous æˆ– Carcinosarcoma ä¹‹åµå·¢ç™Œã€‚",
             "è…«ç˜¤æª¢é«”ç¶“ä¸­å¤®æª¢æ¸¬ç‚º FRÎ± Expression Positiveã€‚",
             "Part A (PROC): æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©æƒ¡åŒ–ï¼›æ›¾æ¥å—é 1â€“3 ç·šå…¨èº«æ²»ç™‚ã€‚",
             "Part B (PSOC): æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ >180 å¤©æƒ¡åŒ–ï¼›å¿…é ˆæ›¾ç”¨é PARPi ä¸¦ç”¢ç”Ÿè€è—¥ã€‚"
         ],
         "exclusion": [
             "å…ˆå‰æ›¾ç”¨éå¸¶æœ‰ Topoisomerase I æŠ‘åˆ¶åŠ‘è¼‰è·ä¹‹ ADC (å¦‚ DS-8201)ã€‚",
             "é¡¯è‘—è›‹ç™½å°¿ (UPCR â‰¥ 2.0) æˆ–æ´»å‹•æ€§ ILD ç—…å²ã€‚"
         ], "ref": "NCT06536348"},
        
        {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd (Raludotatug Deruxtecan)", "pos": "R-TX", "sub_pos": ["PROC"], 
         "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCï¼Œæ­è¼‰å¼·æ•ˆ DXd è¼‰è·ã€‚å…·å‚™æ¥µé«˜ DAR èˆ‡å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ï¼Œèƒ½é‡å°ç•°è³ªæ€§å¼·çš„ PROC ç”¢ç”Ÿé¡¯è‘—æ®ºå‚·æ•ˆæœã€‚",
         "dosing": {"Exp Arm": "R-DXd 5.6 mg/kg IV Q3Wã€‚", "Control Arm": "ç ”ç©¶è€…é¸æ“‡åŒ–ç™‚ (Paclitaxel, PLD, or Topotecan)ã€‚"},
         "outcomes": {"ORR": "46.0%", "mPFS": "7.1m", "HR": "Phase 3", "CI": "NCT06161025", "AE": "ILD Risk, å™å¿ƒ"},
         "inclusion": ["HG Serous æˆ– Endometrioid åµå·¢ç™Œ", "Platinum-resistant (PROC)", "æ›¾æ¥å— 1-4 ç·šæ²»ç™‚", "éœ€æ›¾ç”¨é Bevacizumab"],
         "exclusion": ["Low-grade è…«ç˜¤", "å…·æœ‰ ILD è‚ºéƒ¨ç—…å²", "LVEF < 50%"], "ref": "JCO 2024"},
        
        {"cancer": "Ovarian", "name": "TroFuse-021 (MK-2870)", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD negative / Unknown"], 
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°çš„ ICD æ•ˆæ‡‰ï¼Œå„ªåŒ– pHRD æ—ç¾¤åœ¨ä¸€ç·šç¶­æŒæ™‚çš„ç²ç›Šã€‚",
         "dosing": {"Arm 1": "Sac-TMT å–®è—¥ç¶­æŒã€‚", "Arm 2": "Sac-TMT + Beva 15mg/kg Q3Wã€‚", "Arm 3": "Observation / Bevaã€‚"},
         "outcomes": {"ORR": "Est 40%", "mPFS": "æ‹›å‹Ÿä¸­", "HR": "Phase 3", "CI": "NCT06241729", "AE": "å£è…”ç‚, è…¹ç€‰"},
         "inclusion": ["æ–°è¨ºæ–· FIGO III/IV åµå·¢ç™Œ", "HRD negative (pHRD) / BRCA WT", "1Lå«é‰‘å¾Œ CR/PR"],
         "exclusion": ["BRCA çªè®Šæˆ– HRD é™½æ€§", "å…ˆå‰ç”¨é Trop-2 ADC"], "ref": "ENGOT-ov85"},
        
        {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": ["IO Maintenance", "MMRd", "NSMP"], 
         "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ã€‚é€éå…ç–«èª¿ç¯€å¼·åŒ– Pembrolizumab åœ¨ pMMR æˆ– NSMP æ—ç¾¤çš„é•·æœŸæ‡‰ç­”ã€‚",
         "dosing": {"Maintenance Phase": "Pembrolizumab 400 mg Q6W + Sac-TMT 5 mg/kg Q6Wã€‚"},
         "outcomes": {"ORR": "Est 35% Ph 2", "mPFS": "Phase 3", "HR": "Ongoing", "CI": "NCT06132958", "AE": "è²§è¡€, å£è…”ç‚"},
         "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PR"],
         "exclusion": ["å…ˆå‰æ¥å—éæ™šæœŸç³»çµ±æ€§ IO æ²»ç™‚", "å­å®®è‚‰ç˜¤"], "ref": "ESMO 2025"},
        
        {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["pMMR", "p53abn", "NSMP"], 
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚é‡‹æ”¾ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«å¤±æ•—å¾Œä¹‹äºŒ/ä¸‰ç·šæ•‘æ´ã€‚",
         "dosing": {"Exp": "Sacituzumab Govitecan 10mg/kg (D1, D8 Q21D)", "Control": "TPC (Doxo/Taxel)ã€‚"},
         "outcomes": {"ORR": "28.5%", "mPFS": "5.6m", "HR": "0.64", "CI": "NCT03964727", "AE": "å—œä¸­æ€§çƒæ¸›å°‘"},
         "inclusion": ["å¾©ç™¼æ€§ EC (éè‚‰ç˜¤)", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•"],
         "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADC", "æ´»å‹•æ€§ CNS è½‰ç§»"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive"], 
         "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç¶­æŒé¦–é¸ã€‚è¶…é«˜ DAR å„ªå‹¢èƒ½æœ‰æ•ˆå°æŠ— HER2 è¡¨ç¾è€…ã€‚",
         "dosing": {"Standard": "T-DXd 5.4mg/kg Q3W", "Combo": "T-DXd + Beva 15mg/kgã€‚"},
         "outcomes": {"ORR": "46.3% (IHC 3+)", "mPFS": "10.4m", "HR": "0.42", "CI": "NCT04482309", "AE": "ILD Risk"},
         "inclusion": ["HER2 IHC 1+/2+/3+", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)"],
         "exclusion": ["ILD è‚ºéƒ¨ç—…å²", "LVEF < 50%"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DOVE", "pharma": "GSK", "drug": "Dostarlimab + Beva", "pos": "R-TX", "sub_pos": ["PROC"], 
         "rationale": "é‡å° OCCC é€æ˜ç´°èƒç™Œå…ç–«å¾®ç’°å¢ƒã€‚åˆ©ç”¨ PD-1 + VEGF é›™é‡é˜»æ–·æ¢å¾© T ç´°èƒæµ¸æ½¤ã€‚",
         "dosing": {"Combo": "Dostarlimab + Bev Q3W", "Control": "Chemo (Gem/PLD/Taxel)ã€‚"},
         "outcomes": {"ORR": "40.2%", "mPFS": "8.2m", "HR": "0.58", "CI": "NCT06023862", "AE": "é«˜è¡€å£“"},
         "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)"],
         "exclusion": ["å…ˆå‰æ¥å—éä»»ä½•å…ç–«æ²»ç™‚"], "ref": "JCO 2025"},

        {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"], 
         "rationale": "æ¨™é¶ Tissue Factor (TF) ADCã€‚æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ï¼Œæ”¹å–„ OSã€‚",
         "dosing": {"Exp Arm": "Tisotumab vedotin 2.0mg/kg Q3W", "Control Arm": "Chemo (TPC)ã€‚"},
         "outcomes": {"ORR": "17.8%", "mPFS": "4.2m", "HR": "0.70", "CI": "NEJM 2024", "AE": "çœ¼è¡¨æ¯’æ€§"},
         "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œ", "å…ˆå‰ 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•"],
         "exclusion": ["åš´é‡çœ¼ç–¾/è§’è†œç‚"], "ref": "NEJM 2024"}
    ]

# --- 3. å´é‚Šæ¬„ï¼šAI åª’åˆåŠ©ç† (ä¿®å¾© 404 åç¨±) ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = st.session_state.trials_db[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI è‡¨åºŠåª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­· (å«åˆ†å­æ¨™è¨˜)", height=250, placeholder="ä¾‹ï¼š62y/o EC, NSMP, Grade 3...")
        if st.button("ğŸš€ é–‹å§‹è‡¨åºŠåˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    # ä¿®æ­£é»ï¼šä½¿ç”¨ gemini-1.5-flash ä»¥ç¢ºä¿ API ç›¸å®¹æ€§
                    model = genai.GenerativeModel('gemini-1.5-flash')
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚åƒè€ƒè©¦é©—ï¼š{st.session_state.trials_db}ã€‚è«‹ä¾æ“š FIGO 2023 äºå‹æˆ– MOC åˆ†æµå»ºè­°è©¦é©—èˆ‡ç†ç”±ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 4. ä¸»é é¢ï¼šç·Šæ¹Šå°èˆªå„€è¡¨æ¿ ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªå„€è¡¨æ¿ (2026 SoC & Molecular)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

st.subheader("ç¬¬äºŒæ­¥ï¼šé»æ“Šå½©è‰²æ¨™è¨˜æŸ¥çœ‹äº®é» (SoC èˆ‡è©¦é©—å°æ‡‰)")
cols = st.columns(4)
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        # å¤§éšæ®µæ–¹å¡Šï¼šé«˜åº¦éš¨å…§å®¹æ’é–‹ï¼Œé›¶ç•™ç™½
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # å°‹æ‰¾åŒ¹é…è©¦é©—ï¼šä¾ sub_pos èˆ‡æ¨™é¡ŒåŒ¹é…
            relevant_trials = [t for t in st.session_state.trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            
            if relevant_trials:
                for t in relevant_trials:
                    label = f"{t['pharma']} | {t['name']} | {t['drug']}"
                    ukey = f"btn_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    with st.popover(label, use_container_width=True):
                        st.markdown(f"#### âœ¨ {t['name']} è‡¨åºŠè§£æ")
                        st.info(f"**Rationale:** {t['rationale'][:160]}...")
                        if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
                            st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 5. æ·±åº¦åˆ†æçœ‹æ¿ ---
st.divider()
t_options = [t["name"] for t in st.session_state.trials_db if t["cancer"] == cancer_type]
try: curr_idx = t_options.index(st.session_state.selected_trial)
except: curr_idx = 0

if t_options:
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›è©³ç´°è©¦é©—å ±å‘Šï¼š", t_options, index=curr_idx)
    t = next(it for it in st.session_state.trials_db if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<span class='pharma-badge'>{t['pharma']}</span>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

    r1, r2 = st.columns([1.3, 1])
    with r1:
        st.markdown("<div class='info-box-blue' style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Dosing Protocol & Rationale</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        for arm, details in t['dosing'].items(): st.write(f"ğŸ”¹ **{arm}**: {details}")
        st.markdown("---")
        st.success(f"**æ©Ÿè½‰å¯¦è­‰ (Rationale):** {t['rationale']}")

    with r2:
        st.markdown("<div class='info-box-gold' style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Efficacy & Outcomes</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div class='hr-display' style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
                <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Hazard Ratio (HR) / NCT ID</div>
                <div class='hr-big-val'>{t['outcomes']['HR']}</div>
                <div class='hr-ci' style='font-size:18px; color:#5D4037; font-weight:700;'>{t['outcomes']['CI']}</div>
            </div>
        """, unsafe_allow_html=True)
        st.write(f"**ORR:** {t['outcomes']['ORR']} | **mPFS:** {t['outcomes']['mPFS']}")
        st.error(f"**Safety / AE:** {t['outcomes']['AE']}")

    st.divider()
    r3, r4 = st.columns(2)
    with r3:
        st.markdown("<div class='info-box-blue' style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for inc in t['inclusion']: st.write(f"â€¢ **{inc}**")
    with r4:
        st.markdown("<div class='info-box-blue' style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for exc in t['exclusion']: st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
